Evidence map›Paper›PMID 39975685›Full record

ArticleFrontiers in medicine2025

Comparative analysis of clinical characteristics and outcomes between carbapenem-resistant and carbapenem-sensitive

Bu Wang, Wei Zhang, Hongxia Zhang, Maochen Li, Zhihua Zhang, Xiaocui Peng, Na Wang, Ning Song

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Carbapenem-ResistantMicroorganisms · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bu WangDepartment of Infectious Diseases, Hebei Medical University, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China.
Wei Zhang *Central Laboratory, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei Province, China.
Hongxia Zhang *Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Hebei North University, Hebei North University, Zhangjiakou, Hebei Province, China.
Maochen Li *Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Hebei North University, Hebei North University, Zhangjiakou, Hebei Province, China.
Zhihua ZhangDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Hebei North University, Hebei North University, Zhangjiakou, Hebei Province, China.
Xiaocui PengDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Hebei North University, Hebei North University, Zhangjiakou, Hebei Province, China.
Na WangAdministration Department of Nosocomial Infection, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei Province, China.
Ning SongDepartment of Infectious Diseases, Hebei Medical University, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To compare the risk factors, clinical outcomes, and mortality rates between carbapenem-resistant Methods: A retrospective cohort study was conducted on patients with Results: The study included 283 patients, with 104 (36.7%) infected by CRKP and 179 (63.3%) by CSKP. CRKP patients had significantly higher body temperature, white blood cell counts, and inflammatory markers, while showing lower diastolic blood pressure and oxygen saturation ( Conclusion: Patients with CRKP infections had higher mortality rates and longer hospital stays than those with CSKP infections. Previous hospitalization, hospitalization in an ICU, and mechanical ventilation were independent risk factors for CRKP infection.

Indexed as

30-day mortalityantibioticclinical outcomesdrug resistant bacteriaodds ratio

Identifiers

PMID39975685
PMCPMC11836024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.